The incidence rate of Hand, Foot and Mouth disease caused by EV71 within the second year observation period after the second vaccination Within the second year after the second vaccination [clinicaltrials_resource:f47038cb7a57f9dfbdae3f9d8c626fae]
to evaluate the efficacy of EV71 vacccine against HFMD caused by EV71
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
The incidence rate of Hand, Foot and Mouth disease caused by EV71 within the second year observation period after the second vaccination Within the second year after the second vaccination [clinicaltrials_resource:f47038cb7a57f9dfbdae3f9d8c626fae]
to evaluate the efficacy of EV71 vacccine against HFMD caused by EV71
Bio2RDF identifier
f47038cb7a57f9dfbdae3f9d8c626fae
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f47038cb7a57f9dfbdae3f9d8c626fae
measure [clinicaltrials_vocabulary:measure]
The incidence rate of Hand, Fo ...... d after the second vaccination
time frame [clinicaltrials_vocabulary:time-frame]
Within the second year after the second vaccination
description
to evaluate the efficacy of EV71 vacccine against HFMD caused by EV71
identifier
clinicaltrials_resource:f47038cb7a57f9dfbdae3f9d8c626fae
title
The incidence rate of Hand, Fo ...... r after the second vaccination
@en
type
label
The incidence rate of Hand, Fo ...... 038cb7a57f9dfbdae3f9d8c626fae]
@en